Coherus BioSciences, Inc.
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the…
Biotechnology
US, Redwood City [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Coherus BioSciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCoherus BioSciences, Inc. can't present revenue by segment